For all analyzed methods (EU-TIRADS, BRAF, miRNAs), the ability to differentiate benign lesions and cancers as measured by the area under the ROC curve was higher for AUS-nuclear nodules than for AUS-other nodules (Table 2 and Table 3). Here, BRAF is linked to cancer.